Abstract
A 60-year-old man with choroidal melanoma was treated with fractionated stereotactic radiotherapy and followed for 6 years. During this period, the tumor has not changed in size, and the patient has experienced only a slight decrease in visual acuity. In this case, stereotactic radiotherapy appears to have been safe and effective and may also be a cost-effective alternative to particle or plaque therapy.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Choroid Neoplasms / diagnostic imaging
-
Choroid Neoplasms / pathology
-
Choroid Neoplasms / surgery*
-
Dose Fractionation, Radiation
-
Follow-Up Studies
-
Fundus Oculi
-
Humans
-
Magnetic Resonance Imaging
-
Male
-
Melanoma / diagnostic imaging
-
Melanoma / pathology
-
Melanoma / surgery*
-
Middle Aged
-
Radiosurgery / methods*
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
Visual Acuity